Mechanism of Action: Neuraminidase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Neuraminidase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laurus | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 218565-002 | May 1, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd Iii | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 209438-002 | Feb 23, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Zydus Pharms | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | FOR SUSPENSION;ORAL | 209113-001 | Sep 14, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Macleods Pharms Ltd | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 207211-001 | Sep 14, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |